SVF-Treo Study: Influence of Cardiac and Respiratory Pulsatility Deformation
SVF-Treo
Investigating the Influence of Cardiac and Respiratory Pulsatility Deformation on the Abdominal Aorta Before and After the Implantation of the Fenestrated TREO.
2 other identifiers
observational
25
1 country
6
Brief Summary
This is a national multicenter study with 25 patients with a complex AAA undergoing endovascular repair with the Fenestrated TREO™ stent graft. ECG and respiratory-gated CT scans will be performed pre-operatively, at discharge, after 6 months, and after 12 months follow up. If stent movement is still present in after 12 months, then another scan will be taken at 24 months. To include respiratory gated with the ECG-gated, patients will undergo ECG-gated CT scan during an inspiration breath-hold as well as an expiration breath-hold. This double gated CT scans will allow us to analyse the movement of the stent graft caused by the cardiac cycle and respiratory cycle. The duration of this study is 2.5 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2026
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2028
March 19, 2026
April 1, 2025
1.8 years
March 11, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients who experience treatment success.
Treatment success is defined as freedom from the following: Type I and III endoleak; stent graft migration; AAA enlargement; AAA rupture; conversion to open surgery; significant twists, kinks or obstruction; aneurysm-related patient death.
One year post procedure.
Study Arms (1)
Complex AAA Patients
The entire cohort consists of patients with an abdominal aortic aneurysm eligible for fenestrated endovascular aortic repair using a fenestrated Treo device.
Interventions
ECG-gated CT is a technique in which the ECG of the patient is measured during scanning. This can be used during scanning for instance to apply the most dose in the diastolic phase of the cardiac cycle (where motion is lowest), a technique known as prospective gating. In retrospective gating, the ECG is used to split the data in bins corresponding to a specific phase of the cardiac cycle, and creating one volumetric image per bin. To incorporate the respiratory cycle with the ECG-gated CT scan, an ECG-gated CT scan will be taken during inspirational breath-hold and during expiration breath-hold. Creating one CT scan with two phases, inspiration ECG-gated and an expiration ECG-gated scan. This is the technique that we will be using in this study; it allows us to study the temporal aspects of the data.
Eligibility Criteria
The study population consists of 25 patients with an abdominal aortic aneurysms to be treated with F-EVAR, aged \>65. The study population are patients from either Medisch Spectrum Twente (MST), Rijnstate Ziekenhuis, Jeroen Bosch Ziekenhuis, Amsterdam UMC, UMC Utrecht and Zuyderland Medisch Centrum.
You may qualify if:
- Asymptomatic AAA,
- Age \> 65
- Indication for AAA treatment according to standard practice
- Anatomic suitability for the fenestrated Treo stent graft
- At least one stentable main renal artery and one other stentable renal or mesenteric artery
- Being able to hold their breath for 10 seconds.
You may not qualify if:
- No informed consent obtained
- eGFR \< 30 ml/min
- Allergy for intra venous contrast fluid.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Rijnstate Ziekenhuis
Arnhem, Gelderland, 6815AD, Netherlands
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, North Brabant, 5223 GZ, Netherlands
Amsterdam UMC
Amsterdam, North Holland, 1105AZ, Netherlands
Medisch Spectrum Twente
Enschede, Overijssel, 7512KZ, Netherlands
UMC Utrecht
Utrecht, Utrecht, 3584 CX, Netherlands
Zuyderland Medisch Centrum
Heerlen, 6419PC, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert H Geelkerken
University of Twente
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinating Investigator
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 16, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
January 31, 2028
Last Updated
March 19, 2026
Record last verified: 2025-04